A study identifies cGAS–STING hyperactivation as a mechanism that may help explain the elevated risk of liver inflammation seen in individuals with Down syndrome. By linking innate immune sensing to hepatic inflammation biology, the findings narrow the mechanistic gap behind multi-organ susceptibility and support efforts to consider pathway-targeted strategies in DS-associated inflammation.